These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 21349071)

  • 21. Cost-effectiveness analysis: can we reduce variability in costing methods?
    Adam T; Koopmanschap MA; Evans DB
    Int J Technol Assess Health Care; 2003; 19(2):407-20. PubMed ID: 12862197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methodological considerations in the analysis of cost effectiveness in dentistry.
    Antczak-Bouckoms AA; Tulloch JF; White BA; Capilouto EI
    J Public Health Dent; 1989; 49(4):215-22. PubMed ID: 2509689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-benefit analysis: a research tool for evaluating innovative health programs.
    Bootman JL; Rowland C; Wertheimer AI
    Eval Health Prof; 1979 Jun; 2(2):129-54. PubMed ID: 10308892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Essentials of health economics: Part V. Assessing the cost and benefits of treatment alternatives.
    Drummond MF; Mooney GH
    Br Med J (Clin Res Ed); 1982 Dec; 285(6355):1638-9 contd. PubMed ID: 6814685
    [No Abstract]   [Full Text] [Related]  

  • 25. Using discrete choice experiments within a cost-benefit analysis framework: some considerations.
    McIntosh E
    Pharmacoeconomics; 2006; 24(9):855-68. PubMed ID: 16942121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential transferability of economic evaluations of programs encouraging physical activity in children and adolescents across different countries--a systematic review of the literature.
    Korber K
    Int J Environ Res Public Health; 2014 Oct; 11(10):10606-21. PubMed ID: 25321876
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Assessment of the contribution of public health workers toward increasing the efficiency of social production].
    Popov GA
    Sov Zdravookhr; 1982; (10):10-5. PubMed ID: 6815805
    [No Abstract]   [Full Text] [Related]  

  • 28. Cost-benefit analysis: a helpful tool for decision makers?
    Dinkel RH
    Health Policy; 1985; 4(4):321-30. PubMed ID: 10311129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Economic evaluation in health care: an introduction for psychiatrists.
    McGuire A; Drummond M
    Soc Psychiatry Psychiatr Epidemiol; 1993 Oct; 28(5):211-7. PubMed ID: 8284733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New Cost-Effectiveness Methods to Determine Value-Based Prices for Potential Cures: What Are the Options?
    Pearson SD; Ollendorf DA; Chapman RH
    Value Health; 2019 Jun; 22(6):656-660. PubMed ID: 31198182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Applications of cost-effectiveness analysis for evaluation of health care programs.
    Newacheck PW; McManus M
    Mobius; 1985 Oct; 5(4):55-63. PubMed ID: 10311314
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Health service efficiency: appraising the appraisers--a critical review of economic appraisal in practice.
    Blades CA; Culyer AJ; Walker A
    Soc Sci Med; 1987; 25(5):461-72. PubMed ID: 3118478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparing health care options using the cost-benefit utility ratio.
    Steinbach JH; Hardison WG
    JAMA; 1986 Feb; 255(6):747. PubMed ID: 3080613
    [No Abstract]   [Full Text] [Related]  

  • 34. Cost effectiveness league tables.
    Michaels J
    BMJ; 1993 Apr; 306(6884):1072. PubMed ID: 8490527
    [No Abstract]   [Full Text] [Related]  

  • 35. Cost analysis of schistosomiasis.
    Bundy DA; Guyatt HL
    Trans R Soc Trop Med Hyg; 1992; 86(6):646-8. PubMed ID: 1287932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Can an economic case be made for investing in health?. No, but it's the wrong question.
    Normand C
    BMJ; 1998 Jun; 316(7147):1762. PubMed ID: 9624059
    [No Abstract]   [Full Text] [Related]  

  • 37. A world class health service in the quality of staff and cost effectiveness.
    Abbasi K
    J R Soc Med; 2022 Mar; 115(3):85. PubMed ID: 35261314
    [No Abstract]   [Full Text] [Related]  

  • 38. The Cost of Costing Treatments Incorrectly: Errors in the Application of Drug Prices in Economic Models Due to Differing Patient Weights.
    Hatswell AJ; Porter J; Hertel N; Lee D
    Value Health; 2014 Nov; 17(7):A323-4. PubMed ID: 27200530
    [No Abstract]   [Full Text] [Related]  

  • 39. Cost-effectiveness of heart failure therapies.
    Rohde LE; Bertoldi EG; Goldraich L; Polanczyk CA
    Nat Rev Cardiol; 2013 Jun; 10(6):338-54. PubMed ID: 23609174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Economic analyses of breast cancer control in low- and middle-income countries: a systematic review.
    Zelle SG; Baltussen RM
    Syst Rev; 2013 Apr; 2():20. PubMed ID: 23566447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.